(Q41071790)

26 September 2017

title

Downregulation of Fas ligand by shedding (English)

1 reference

26 September 2017

Tanaka M

1

1 reference

26 September 2017

Itai T

series ordinal

2

1 reference

26 September 2017

Adachi M

series ordinal

3

1 reference

26 September 2017

Nagata S

series ordinal

4

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

26 September 2017

1 reference

26 September 2017

volume

4

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

31-36

1 reference

Apoptosis by death factor

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

Human native soluble CD40L is a biologically active trimer, processed inside microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

A metalloprotease-disintegrin participating in myoblast fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

A role for CD95 ligand in preventing graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

Expression of the functional soluble form of human fas ligand in activated lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Fas ligand in human serum

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

https://api.crossref.org/works/10.1038%2FNM0198-031

1 reference

7 January 2021

Fas-mediated cytotoxicity by freshly isolated natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Essential roles of the Fas ligand in the development of hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

The role of Fas in autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Establishment of apoptosis‐inducing monoclonal antibody 2D1 and 2D1‐resistant variants of human T cell lines

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Fas-mediated apoptosis in primary cultured mouse hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Human Fas ligand: gene structure, chromosomal location and species specificity

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Cleavage of membrane-bound CD40 ligand is not required for inducing B cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Antitumor effect of locally produced CD95 ligand

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

pEF-BOS, a powerful mammalian expression vector

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-031

7 January 2021

Identifiers

DOI

10.1038/NM0198-031

1 reference

26 September 2017

1 reference